BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts
BioNTech stock tumbled Wednesday after the Covid vaccine maker reported light fourth-quarter sales and profit.
BioNTech stock tumbled Wednesday after the Covid vaccine maker reported light fourth-quarter sales and profit.